Oxytocin

DB00107ApprovedInvestigationalVet approvedProtein Based TherapiesUterotonic agents

Oxytocin is a recombinant hormone used to induce or strengthen uterine contractions in pregnant women to aid in labor and delivery or to control postpartum bleeding. Sir Henry H. Dale first identified oxytocin and its uterine contractile properties in 1906.

Protein structure of Oxytocin
Mechanism
Curator reviewed · 15 references
Primary indication
Administration of exogenous oxytocin is indicated in the antepartum period to initiate or improve uterine contractions for vaginal delivery in situations where there is fetal or maternal concern.Curator reviewed · 7 structured indications
Formula / weight
C43H66N12O12S2 · 1007.187 Da
First approval
Canada, 2017 · United States, 1980
Brand names
  • Pitocin

Resolves to

Transporters

What you can answer from here — as of July 17, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
427Drug interactionsStructured to mechanism, not free text
Sign in
503Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
9ContraindicationsEach with its own population and attribute set
Sign in
97Marketed productsAcross 10 countries and 56 labellers
Sign in
2ATC codesIncluding every combination product, plus 18 drug categories
Sign in
42+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Oxytocin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account